Model Structure of Human APOBEC3G

Background APOBEC3G (apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G) has antiretroviral activity associated with the hypermutation of viral DNA through cytosine deamination. APOBEC3G has two cytosine deaminase (CDA) domains; the catalytically inactive amino-terminal domain of APOBEC3G (N-CDA) carries the Vif interaction domain. There is no 3-D structure of APOBEC3G solved by X-ray or nuclear magnetic resonance. Methodology/Principal Findings We predicted the structure of human APOBEC3G based on the crystal structure of APOBEC2. To assess the model structure, we evaluated 48 mutants of APOBEC3G N-CDA that identify novel variants altering ΔVif HIV-1 infectivity and packaging of APOBEC3G. Results indicated that the key residue D128 is exposed at the surface of the model, with a negative local electrostatic potential. Mutation D128K changes the sign of that local potential. In addition, two novel functionally relevant residues that result in defective APOBEC3G encapsidation, R122 and W127, cluster at the surface. Conclusions/Significance The structure model identifies a cluster of residues important for packaging of APOBEC3G into virions, and may serve to guide functional analysis of APOBEC3G.

[1]  Andras Fiser,et al.  Proteomic profiling of the granular cell layer from rats submitted to the experimental model of temporal lobe epilepsy , 2013 .

[2]  M. Malim,et al.  Identification of Amino Acid Residues in APOBEC3G Required for Regulation by Human Immunodeficiency Virus Type 1 Vif and Virion Encapsidation , 2007, Journal of Virology.

[3]  M. Klein,et al.  The APOBEC-2 crystal structure and functional implications for the deaminase AID , 2007, Nature.

[4]  M. Yap,et al.  All Three Variable Regions of the TRIM5α B30.2 Domain Can Contribute to the Specificity of Retrovirus Restriction , 2006, Journal of Virology.

[5]  Xiao-Fang Yu.  Innate cellular defenses of APOBEC3 cytidine deaminases and viral counter-defenses , 2006, Current opinion in HIV and AIDS.

[6]  A. Telenti,et al.  Patterns of evolution of host proteins involved in retroviral pathogenesis , 2006, Retrovirology.

[7]  B. Cullen.  Role and Mechanism of Action of the APOBEC3 Family of Antiretroviral Resistance Factors , 2006, Journal of Virology.

[8]  Liam J. McGuffin,et al.  Protein structure prediction servers at University College London , 2005, Nucleic Acids Res..

[9]  M. Malim,et al.  Cytidine deamination and resistance to retroviral infection: towards a structural understanding of the APOBEC proteins. , 2005, Virology.

[10]  R. König,et al.  Complementary function of the two catalytic domains of APOBEC3G. , 2005, Virology.

[11]  M. Malim,et al.  Antiviral Function of APOBEC3G Can Be Dissociated from Cytidine Deaminase Activity , 2005, Current Biology.

[12]  Xianghui Yu,et al.  Amino-Terminal Region of the Human Immunodeficiency Virus Type 1 Nucleocapsid Is Required for Human APOBEC3G Packaging , 2004, Journal of Virology.

[13]  D. Pérez-Caballero,et al.  APOBEC3G Incorporation into Human Immunodeficiency Virus Type 1 Particles , 2004, Journal of Virology.

[14]  B. Cullen,et al.  Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor. , 2004, Virology.

[15]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[16]  V. Pathak,et al.  Human Apolipoprotein B mRNA-editing Enzyme-catalytic Polypeptide-like 3G (APOBEC3G) Is Incorporated into HIV-1 Virions through Interactions with Viral and Nonviral RNAs* , 2004, Journal of Biological Chemistry.

[17]  L. Kleiman,et al.  The Interaction between HIV-1 Gag and APOBEC3G* , 2004, Journal of Biological Chemistry.

[18]  J. Wedekind,et al.  The structure of a yeast RNA-editing deaminase provides insight into the fold and function of activation-induced deaminase and APOBEC-1. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[19]  V. Pathak,et al.  A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  D. Trono,et al.  A Single Amino Acid Determinant Governs the Species-specific Sensitivity of APOBEC3G to Vif Action* , 2004, Journal of Biological Chemistry.

[21]  B. Cullen,et al.  A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[22]  N. Landau,et al.  A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif). , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[23]  A. Kierzek,et al.  Domain organization of activation-induced cytidine deaminase , 2003, Nature Immunology.

[24]  Reuben S Harris,et al.  The Vif Protein of HIV Triggers Degradation of the Human Antiretroviral DNA Deaminase APOBEC3G , 2003, Current Biology.

[25]  A. Fischer,et al.  AID mutant analyses indicate requirement for class-switch-specific cofactors , 2003, Nature Immunology.

[26]  J. Wedekind,et al.  Messenger RNA editing in mammals: new members of the APOBEC family seeking roles in the family business. , 2003, Trends in genetics : TIG.

[27]  M. Malim,et al.  Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein , 2002, Nature.

[28]  L. Serrano,et al.  Predicting changes in the stability of proteins and protein complexes: a study of more than 1000 mutations. , 2002, Journal of molecular biology.

[29]  Liam J. McGuffin,et al.  The PSIPRED protein structure prediction server , 2000, Bioinform..

[30]  D T Jones,et al.  Protein secondary structure prediction based on position-specific scoring matrices. , 1999, Journal of molecular biology.

[31]  N. Navaratnam,et al.  Molecular modelling and the biosynthesis of apolipoprotein B containing lipoproteins. , 1998, Atherosclerosis.

[32]  F. Melo,et al.  Assessing protein structures with a non-local atomic interaction energy. , 1998, Journal of molecular biology.

[33]  Alexander D. MacKerell,et al.  All-atom empirical potential for molecular modeling and dynamics studies of proteins. , 1998, The journal of physical chemistry. B.

[34]  C Carter,et al.  Escherichia coli cytidine deaminase provides a molecular model for ApoB RNA editing and a mechanism for RNA substrate recognition. , 1998, Journal of molecular biology.

[35]  Francisco Melo,et al.  ANOLEA: A WWW Server to Assess Protein Structures , 1997, ISMB.

[36]  F. Melo,et al.  Novel knowledge-based mean force potential at atomic level. , 1997, Journal of molecular biology.

[37]  L. R. Scott,et al.  Electrostatics and diffusion of molecules in solution: simulations with the University of Houston Brownian dynamics program , 1995 .

[38]  James Scott,et al.  Evolutionary origins of apoB mRNA editing: Catalysis by a cytidine deaminase that has acquired a novel RNA-binding motif at its active site , 1995, Cell.

[39]  T. Blundell,et al.  Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.

[40]  W. Kabsch,et al.  Dictionary of protein secondary structure: Pattern recognition of hydrogen‐bonded and geometrical features , 1983, Biopolymers.

[41]  M. Karplus,et al.  CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .

[42]  Fanny Meunier,et al.  Interplay between acoustic/phonetic and semantic processes during spoken sentence comprehension: An ERP study , 2011, Brain and Language.

[43]  H. Matsuo,et al.  Dancin' deaminase , 2006, Nature Structural &Molecular Biology.

[44]  James A. Cuff,et al.  The Jalview Java alignment editor , 2004, Bioinform..

[45]  A. Sali,et al.  Modeling of loops in protein structures , 2000, Protein science : a publication of the Protein Society.